Table 3.
Means QOL scores over time
| PC group (n = 34), mean (SD) | VGD group (n = 34), mean (SD) | |||||||
|---|---|---|---|---|---|---|---|---|
| Assessment time | Baseline | 6 week | 12 week | 18 week | Baseline | 6 week | 12 week | 18 week |
| FACT-G | ||||||||
| Physical well-being (7 items) | 21.8 (5.3) | 16.9 (7.1) | 16.1 (5.4) | 12.8 (5.7) | 21.4 (5.3) | 19.1 (6.7) | 20.2 (6.2) | 20.2 (5.1) |
| Social/family well-being (7 items) | 19.7 (4.7) | 19.7 (5.0) | 18.9 (6.2) | 19.4 (5.2) | 18.9 (6.0) | 19.6 (4.9) | 20.1 (5.1) | 17.2 (6.0) |
| Emotional well-being (6 items) | 16.1 (5.1) | 15.6 (5.9) | 15.5 (6.4) | 13.6 (5.6) | 14.1 (5.8) | 16.3 (5.5) | 16.8 (5.1) | 16.4 (5.5) |
| Functional well-being (7 items) | 17.5 (6.7) | 14.9 (6.3) | 15.2 (6.6) | 13.1 (5.4) | 16.2 (6.9) | 17.2 (6.5) | 19.2 (6.0) | 16.4 (7.2) |
| FACT-G total (27 items) | 73.0 (15.4) | 65.1 (17.5) | 63.4 (17.4) | 57.1 (14.7) | 69.0 (12.8) | 70.3 (16.7) | 74.6 (15.7) | 68.9 (16.5) |
| FACT-L | ||||||||
| Lung cancer subscale (7 items) | 19.0 (5.1) | 19.3 (3.8) | 19.3 (4.8) | 18.8 (4.2) | 18.9 (3.7) | 18.9 (6.0) | 20.3 (4.5) | 20.4 (5.1) |
| Trial outcome index-lung (21 items) | 57.6 (12.5) | 51.2 (13.3) | 49.9 (13.8) | 44.6 (10.6) | 56.2 (10.8) | 55.1 (15.9) | 59.7 (14.2) | 57.0 (14.8) |
| FACT-Taxane | ||||||||
| Neurotoxicity (11 items) | 40.3 (4.1) | 30.0 (9.4) | 24.3 (9.3) | 16.0 (7.2) | 39.6 (5.6) | 37.4 (7.2) | 38.9 (5.5) | 37.0 (7.0) |
| Taxane (16 items) | 59.9 (4.3) | 47.5 (12.0) | 41.0 (11.7) | 30.4 (9.9) | 59.1 (6.8) | 56.5 (8.9) | 58.3 (6.1) | 55.4 (9.3) |
| Trial outcome index-taxane (30 items) | 98.9 (13.7) | 78.9 (21.2) | 70.9 (17.4) | 55.8 (15.9) | 96.7 (11.9) | 92.5 (18.0) | 97.7 (15.1) | 91.8 (16.8) |
| FACIT-Sp | ||||||||
| Spirituality (12 items) | 30.3 (9.8) | 30.1 (9.6) | 28.3 (11.8) | 27.2 (12.4) | 28.4 (11.5) | 29.6 (9.8) | 28.3 (11.4) | 30.0 (9.4) |